These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4358414)

  • 1. Proceedings: Concentrations of the oxime 2-hydroxyiminomethyl pyridinium methyl methane sulphonate (P2S) after intramuscular injections in humans.
    Holland P; Parkes D; Shakespeare J
    Br J Pharmacol; 1972 Feb; 44(2):368P. PubMed ID: 4358414
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Lethal plasma concentrations of pralidoxime methane sulphonate (P2S) given parenterally.
    Ballantyne B; Gazzard MF; Robson OC; Swanston DW
    Br J Pharmacol; 1974 May; 51(1):119P-120P. PubMed ID: 4441769
    [No Abstract]   [Full Text] [Related]  

  • 3. Aqueous humour pralidoxime mesylate (P2S) concentrations and intraocular tension following intramuscular P2S.
    Ballantyne B; Swanston DW
    Drug Chem Toxicol; 1980; 3(3):259-75. PubMed ID: 6256147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of the oxime Pralidoxime Mesylate (P2S) after repeated oral and intramuscular administration.
    Holland P; Parkes DC
    Br J Ind Med; 1976 Feb; 33(1):43-6. PubMed ID: 1268107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atropine sulphate absorption in humans after intramuscular injection of a mixture of the oxime-P2S and atropine.
    Holland P; White RG
    Br J Pharmacol; 1971 Aug; 42(4):645P-646P. PubMed ID: 5116047
    [No Abstract]   [Full Text] [Related]  

  • 6. Pralidoxime mesylate absorption and heart rate response to atropine sulphate following intramuscular administration of solution mixtures.
    Holland P; Parkes DC; White RG
    Br J Clin Pharmacol; 1975 Aug; 2(4):333-8. PubMed ID: 788732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atropine sulphate absorption from an intramuscular injection of a mixture of the oxime, P2S, and atropine in exercising humans.
    Martin Hde V
    Br J Pharmacol; 1973 Mar; 47(3):619P. PubMed ID: 4354327
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrations of 2-hydroxyiminomethyl-N-methylpyridinium ion in plasma and aqueous humor as indices of the toxicity of pralidoxime mesylate (P2S) for the rabbit.
    Ballantyne B; Gazzard MF; Robson DC; Swanston DW
    Toxicol Appl Pharmacol; 1975 Sep; 33(3):559-67. PubMed ID: 1188951
    [No Abstract]   [Full Text] [Related]  

  • 9. The toxicity of 2-hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S).
    DAVIES DR; WILLEY GL
    Br J Pharmacol Chemother; 1958 Jun; 13(2):202-6. PubMed ID: 13536287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate (P2S), an antidote to organophosphorus poisoning. Its preparation, estimation and stability.
    CREASEY NH; GREEN AL
    J Pharm Pharmacol; 1959 Aug; 11():485-90. PubMed ID: 13812738
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood levels of oxime and symptoms in humans after single and multiple oral doses of 2-pyridine aldoxime methochloride.
    Sidell FR; Groff WA; Ellin RI
    J Pharm Sci; 1969 Sep; 58(9):1093-8. PubMed ID: 5346072
    [No Abstract]   [Full Text] [Related]  

  • 12. Disposition kinetics and dosage regimen of 2-formyl 1-methyl pyridinium oxime (2-PAM) in heifers.
    Srivastava AK; Khanikor HN; Malik JK
    Acta Vet Hung; 1988; 36(3-4):251-6. PubMed ID: 3254091
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood concentrations of N,N'-trimethylenebis(pyridinium-4-aldoxime) (TMB-4) and N,N'-oxydimethlenebis (pyridinium-4-aldoxime) (toxogonin) after intravenous and intramuscular administration in the dog.
    Milosević M; Vojvodić V; Terzić M
    Biochem Pharmacol; 1967 Dec; 16(12):2435-8. PubMed ID: 6075402
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the effects of atropine on human heart rate by pralidoxime.
    Sidell FR; Magness JS; Bollen TE
    Clin Pharmacol Ther; 1970; 11(1):68-76. PubMed ID: 5410897
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pralidoxime mesylate on the measurement of cyanide concentrations in solutions.
    Ballantyne B
    Vet Hum Toxicol; 1984; 26 Suppl 2():23-7. PubMed ID: 6523723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration, and volume.
    Sidell FR; Culver DL; Kaminskis A
    JAMA; 1974 Sep; 229(14):1894-7. PubMed ID: 4479281
    [No Abstract]   [Full Text] [Related]  

  • 18. The stability of pralidoxime methane sulphonate (P2S) and pralidoxime chloride (PAMCI) in aqueous solutions.
    BARKMAN R
    Rev Int Serv Sante Armees; 1963 Feb; 36():91-8. PubMed ID: 13966704
    [No Abstract]   [Full Text] [Related]  

  • 19. Intramuscular and intravenous administration of small doses of 2-pyridinium aldoxime methochloride to man.
    Sidell FR; Groff WA
    J Pharm Sci; 1971 Aug; 60(8):1224-8. PubMed ID: 4945277
    [No Abstract]   [Full Text] [Related]  

  • 20. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
    Krejcova-Kunesova G; Bartosova L; Kuca K
    Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.